Aytu Biopharma, Inc
AYTU- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001385818
No open-market purchases or sales by Aytu Biopharma, Inc insiders were filed in the last 90 days; 38 institutions reported holding it in 13F filings for Q2 2026, worth $8.25M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Aytu Biopharma, Inc changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 41 | 53 | +12 |
| Shares | 3.62M | 8.86M | +5.24M (+144.9%) |
| Value | $2.50M | $1.64M | −$858.9K (−34.4%) |
New holders (13)
Institutions that held Aytu Biopharma, Inc at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Alyeska Investment Group, L.P. | 1,500,000 | $278.0K | 0.00% |
| Sabby Management, LLC | 1,262,516 | $234.0K | 0.51% |
| Walleye Capital LLC | 582,500 | $108.0K | 0.00% |
| Ayrton Capital LLC | 452,221 | $84.0K | 0.15% |
| CVI Holdings, LLC | 141,877 | $26.0K | 0.00% |
| Warberg Asset Management LLC | 65,002 | $12.0K | 0.00% |
| Susquehanna International Group, LLP | 56,389 | $10.0K | 0.00% |
| Two Sigma Securities, LLC | 20,515 | $4.00K | 0.00% |
| Sigma Planning Corp | 16,996 | $3.00K | 0.00% |
| Jane Street Group, LLC | 13,539 | $3.00K | 0.00% |
| FMR LLC | 12,000 | $2.00K | 0.00% |
| Affinity Capital Advisors, LLC | 11,415 | $2.00K | 0.00% |
| BNP Paribas Arbitrage, SA | 524 | $97 | 0.00% |
Sold out (1)
Institutions that held Aytu Biopharma, Inc at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| D. E. Shaw & Co., Inc. | 18,235 | $13.0K |